###begin article-title 0
###xml 91 96 <span type="species:ncbi:9606">women</span>
Preliminary molecular genetic analysis of the Receptor Interacting Protein 140 (RIP140) in women affected by endometriosis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1 </italic>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1</italic>
###xml 468 474 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1 </italic>
###xml 889 895 889 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 55 60 <span type="species:ncbi:9606">women</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 769 774 <span type="species:ncbi:9606">women</span>
###xml 903 909 <span type="species:ncbi:9606">humans</span>
Endometriosis is a complex disease affecting 10-15% of women at reproductive age. Very few genes are known to be altered in this pathology. RIP140 protein is an important cofactor of oestrogen receptor and many other nuclear receptors. Targeting disruption experiments of nrip1 gene in mice have demonstrated that nuclear receptor interacting protein 1 gene (nrip1), the gene encoding for rip140 protein, is essential for female fertility. Specifically, mice null for nrip1 gene are viable, but females are infertile because of complete failure of mature follicles to release oocytes at ovulation stage. The ovarian phenotype observed in mice devoid of rip140 closely resembles the luteinized unruptured follicle (LUF) syndrome that is observed in a high proportion of women affected of endometriosis or idiopathic infertility. Here we present a preliminary work that analyses the role of NRIP1 gene in humans.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
We have sequenced the complete coding region of NRIP1 gene in 20 unrelated patients affected by endometriosis. We have performed genetic association studies by using the DNA variants identified during the sequencing process.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 500 523 500 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allele positivity test </sub>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
We identified six DNA variants within the coding sequence of NRIP1 gene, and five of them generated amino acid changes in the protein. We observed that three of twenty sequenced patients have specific combinations of amino-acid variants within the RIP140 protein that are poorly represented in the control population (p = 0.006). Moreover, we found that Arg448Gly, a common polymorphism located within NRIP1 gene, is associated with endometriosis in a case-control study (59 cases and 141 controls, pallele positivity test = 0.027).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 115 120 <span type="species:ncbi:9606">human</span>
Our results suggest that NRIP1 gene variants, separately or in combinations, might act as predisposing factors for human endometriosis.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 47 50 <span type="species:ncbi:9606">Man</span>
###xml 52 56 <span type="species:ncbi:9606">OMIM</span>
###xml 110 115 <span type="species:ncbi:9606">women</span>
###xml 395 400 <span type="species:ncbi:9606">women</span>
###xml 494 499 <span type="species:ncbi:9606">women</span>
Endometriosis (Online Mendelian Inheritance in Man (OMIM) 131200) is a complex disease affecting to 10-15% of women at reproductive age. The disease consists in pelvic pain and infertility due to the existence of endometrial glands and stroma outside the uterine cavity [1]. Anovulatory cycles and Luteinized Unruptured Follicle syndrome (LUF) are also evident in a great proportion of affected women [2,3]. Moreover, recurrent pregnancy losses, low quality of oocytes and early embryo loss in women with endometriosis have been suggested [4,5].
###end p 11
###begin p 12
###xml 330 369 330 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nuclear receptor interacting protein 1 </italic>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1</italic>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1 </italic>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 834 835 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1 </italic>
###xml 973 978 973 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1</italic>
###xml 1059 1064 1059 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1</italic>
###xml 1077 1078 1077 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1249 1250 1249 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1251 1252 1251 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1281 1287 1281 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1 </italic>
###xml 1336 1337 1336 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 775 780 <span type="species:ncbi:9606">women</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
###xml 1146 1150 <span type="species:ncbi:10090">mice</span>
Receptor Interacting Protein 140 (RIP140) (Swiss-Prot ) is a high pleiotropic protein that acts as a co-regulator of multiple members of the nuclear receptor super-family including oestrogen, progesterone, retinoid acid or glucocorticoid receptors. Targeting disruption experiments of this function in mice have demonstrated that nuclear receptor interacting protein 1 (nrip1) gene (GenBank ), the gene encoding for rip140 protein, is essential for female fertility [3]. Specifically, mice null for nrip1 gene are viable, but females are infertile because of the complete failure of mature follicles to release oocytes at ovulation stage [3]. The ovarian phenotype observed in mice devoid of rip140 closely resembles the LUF syndrome that is observed in a high proportion of women affected by endometriosis or idiopathic infertility [2,3]. In addition, embryo transfer and ovarian transplantation experiments in nrip1 knock-out mice indicate slightly longer pregnancies in nrip1-/- mice and a high rate of foetal and neonatal losses of pups from mothers with nrip1-/- ovaries [6]. These data suggest that rip140 protein may have two functions in mice ovaries: i) an essential role in ovulation; ii) a secondary role in the maintenance of pregnancy [3,6]. More recently, a role for nrip1 gene in fat accumulation has been also proposed [6].
###end p 12
###begin p 13
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1</italic>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:9606">women</span>
Due to nrip1-/-, female mice have several traits that closely resemble endometriosis findings; we decided to explore the role of the human NRIP1 gene (GenBank ) in women affected by endometriosis. Direct molecular analysis of endometriotic tissue specimens revealed no de novo mutations in 20 affected tissues. However, different germ-line genetic variants have been detected during our study. The involvement of these germline variants with endometriosis is proposed.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 15
###begin p 16
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 276 282 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 431 436 <span type="species:ncbi:9606">women</span>
###xml 510 518 <span type="species:ncbi:9606">patients</span>
Endometriosis was defined according to the endometriosis classification system of the American Society for Reproductive Medicine (1996) [7]. All patients included correspond to stage III or IV of endometriosis. The initial sequencing project analyzed the complete sequence of NRIP1 gene in 20 independent DNA samples obtained from fresh endometriotic tissue derived from peritoneal implants or endometrioma lesions of 20 unrelated women with severe endometriosis. We also obtained fresh blood samples of these patients to test the germ-line or the somatic nature of the DNA variants detected.
###end p 16
###begin p 17
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 254 259 <span type="species:ncbi:9606">women</span>
###xml 699 704 <span type="species:ncbi:9606">women</span>
To perform association studies between NRIP1 gene and human endometriosis, we genotype three groups of individuals. i) We increase the sample size of the case group (endometriosis group) three-fold using germ-line DNA derived from blood of 39 additional women affected by severe endometriosis (Stage III-IV). Therefore, the sample size of the endometriosis group for the association studies conducted was 59 (118 chromosomes). ii) To estimate population frequencies of mutations or polymorphism detected, 94 unselected and unrelated controls from the same geographical region were genotyped in an anonymous fashion (188 chromosomes). iii) A "super-control" group consisted of 47 healthy and fertile women without any sign or symptom of endometriosis, normal response to gonadotrophins and conserved ovulation (94 chromosomes) was also studied.
###end p 17
###begin p 18
###xml 407 415 <span type="species:ncbi:9606">patients</span>
The ethnicity background of all probands and controls was Caucasian (white Europid) minimizing the possibility of population stratification in our case-control studies. The referral centers for this study are the Hospital de Valme (Seville), the Hospital Universitario Virgen de las Nieves (Granada), and the Hospital Principe de Asturias (Alcala de Henares, Madrid). Informed consent was obtained from all patients. The institutional review board of referral centers has approved our research.
###end p 18
###begin title 19
DNA extraction
###end title 19
###begin p 20
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
We obtained 5 ml of peripheral blood from all patients to isolate germline DNA from leukocytes and about 100 mug of fresh endometriotic tissue during a programmed laparoscopic intervention of the patients. DNA extraction was performed according to standard procedures using Nucleospin Blood Kit (Macherey-Nagel) or alternative protocols. To perform Polymerase Chain Reactions (PCRs), we prepared aliquots of DNA at a concentration of 5 ng/mul. The rest of the stock was cryopreserved at -20degreesC.
###end p 20
###begin title 21
Mutation analysis
###end title 21
###begin p 22
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 49 50 49 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
NRIP1 cDNA was first cloned by Cavailles et al. [8]. This gene is mono-exonic, spans 7,239 base pairs (bp) and is located at 21q11.2. Genomic sequence containing NRIP1 gene was identified using the blat tool at UCSC Genome Bioinformatics server . Information concerning any Single Nucleotide Polymorphism (SNP) or mutation identified was compared with the UCSC Genome Bioinformatics server and also with the Single Nucleotide Polymorphism Database (dbSNP) at the National Centre for Biotechnology Information (NCBI) . According to standard mutation nomenclature [9], we employed the most frequent allele in the first position and the rarer allele in the last position.
###end p 22
###begin p 23
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
We employed automated DNA sequencing methods to scan the entire coding sequence of NRIP1 gene in selected specimens. Overlapping PCRs covering the entire gene were designed and PCR products were purified and bi-directionally sequenced using the corresponding pair of primers (Table 1). Sequencing reactions were performed using the CEQ Dye Terminator Cycle Sequencing Quick Start Kit (Beckman Coulter, Inc) according to the manufacture's instructions. Fluorograms were analyzed on CEQtrade mark 8000 Genetic Analysis System following the manufacturer's instructions (Beckman Coulter, Inc).
###end p 23
###begin p 24
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
Amplification primer sequences and PCR product size. NRIP1 is a monoexonic gene. We designed eight overlapping amplicons to cover the entire coding sequence of this gene.
###end p 24
###begin title 25
Genotyping
###end title 25
###begin p 26
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 384 385 384 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
To verify the DNA variants detected during the sequencing process and to perform association studies, we employed Fluorescent Resonance Energy Transfer (FRET) protocols. We designed and synthesized amplification primers and fluorescent detection probes for all the DNA variants identified within the NRIP1 gene. The selected primer pairs and detection probes are summarized in Tables 1 and 2. Real-time PCR was performed in the LightCycler system (Roche Applied Science) using reaction conditions previously published by us [10].
###end p 26
###begin p 27
Anchor and Sensor probes sequences employed for coding Single Nucleotide Polymorphism (cSNP) analysis using Fluorescence Resonance Energy Transfer (FRET) technology.
###end p 27
###begin p 28
Nomenclature: F: Fluoresceine, Ph: Phosphate.
###end p 28
###begin p 29
###xml 551 553 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
The conditions to obtain optimal melting curves for FRET analysis and spectrofluorimetric genotypes were 95degreesC for 0 s, 63degreesC for 25 s, 45degreesC for 0 s and 80degreesC for 0 s (with a temperature-transfer speed of 20degreesC/s in each step, except the last step, in which the speed of temperature transfer was 0.1degreesC/s). In the last step, a continuous fluorometric register was performed fixing the gains of the system at 1, 50, and 50 on channels F1, F2, and F3 respectively. Genotype results using real time-PCR are shown in Figure 1a. To test the specificity of these assays, selected amplicons of different melting patterns were re-sequenced using an automated DNA sequencer (Beckman Coulter CEQ 2000XL, data not shown).
###end p 29
###begin p 30
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Detection of germ line variants in NRIP1 in patients with severe endometriosis. A) Spectrofluorimetric analysis of NRIP1 gene using real-time PCR. Analysis of the fluorescence measured during melting curve determination in the LightCycler (Roche Applied Science). Each allele has a specific melting point and all alleles are represented by its specific nucleotide change with the exception of Ile441Val and Arg448Gly polymorphisms. Nt c.512 G->A (Gly75Gly, melting points, Allele G: 62degreesC; Allele A: 57degreesC). Nt c.949 A->G (His221Arg, melting points, Allele A 61degreesC; Allele G: 56degreesC). Nt c.1608 A->G (Ile441Val) and Nt c.1629 C->G (Arg448Gly) (melting points, Allele Val441: 59degreesC; Allele Gly448: 56degreesC; wild type: 63degreesC). Nt c.2695 C->T (Ser803Leu, melting points, Allele C: 61degreesC; Allele T: 55degreesC). Nt c.3522 G->T (Val1079Phe, melting points, Allele G: 62degreesC; Allele T: 54degreesC). B) Sequence conservation and location of mutations in the RIP-140 protein. Black shading indicates the position of mutations. LXXLL motifs responsible for ligand independent interaction with Retinoid Acid Receptor (RAR) and Retinoid X Receptor (RXR) are in bold and underlyned. Signal peptide is depicted in blue, Carboxyl terminal binding protein (CTBP) and RAR interacting motifs are in red and green respectively. Low complexity regions are shown in grey.
###end p 30
###begin title 31
Statistical Analysis
###end title 31
###begin p 32
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 688 693 <span type="species:ncbi:9606">Human</span>
To compare allele and genotype frequencies between patients, control and super-control groups, we performed conventional chi-square tests with Yates correction or Fisher exact test using Statcalc (EpiInfo 5.1, Center for Disease control, Atlanta, GA). For statistical analysis of genotype distribution, test for deviation of Hardy-Weinberg equilibrium or two-point association studies, we employed six different tests adapted from Sasieni (deviation from Hardy-Weinberg equilibrium, allele frequency differences test, heterozygous test, homozygous test, allele positivity test and Armitage's trend test) [11]. These calculations were performed in the online resource at the Institute for Human Genetics, Munich, Germany . Significant thresholds for statistical studies were fixed at p < 0.05.
###end p 32
###begin title 33
Results
###end title 33
###begin p 34
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 404 410 404 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1073 1079 1073 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 1134 1139 <span type="species:ncbi:9606">human</span>
Looking for somatic mutations within the NRIP1 gene, we determined the complete coding sequence of the candidate gene in 20 selected and unrelated somatic endometriotic tissues using bi-directional automated capillary DNA sequencing. In our primary sequencing project we finished 80,600 bp of DNA. Using our methodology, we identified six single nucleotide DNA variants within the coding sequence of the NRIP1 gene in various unrelated somatic DNA samples. Two of these variants have been previously identified and they are included in the Single Nucleotide Polymorphism Database (dbSNP) at the National Centre for Biotechnology Information (NCBI)  (Table 3). Five of these mutations alter the amino acid coding sequence of RIP140 protein generating missense mutations (Fig. 1 and Table 3). Although all mutations were detected in somatic DNA, direct molecular analyses of the corresponding blood samples of mutated tissue also contain the same DNA change. This last result implies that the genetic variants identified are germ-line and, consequently, somatic mutations at NRIP1 locus are not commonly involved in the pathogenesis of human endometriosis.
###end p 34
###begin p 35
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
Summary of DNA variants observed within the coding sequence of the NRIP1 gene.
###end p 35
###begin p 36
*In accordance with genbank number .
###end p 36
###begin p 37
** dbSNP: the Single Nucleotide Polymorphism Database at the National Centre for Biotechnology Information (NCBI)
###end p 37
###begin p 38
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 370 376 370 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 172 177 <span type="species:ncbi:9606">women</span>
###xml 451 456 <span type="species:ncbi:9606">women</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
###xml 529 534 <span type="species:ncbi:9606">women</span>
To evaluate the polygenic role of NRIP1 gene variants in human endometriosis, we decided to preliminary explore the allelic frequencies and genotypes of these mutations in women affected by endometriosis and unselected controls. To conduct genetic association studies, we developed real-time PCR detection protocols using FRET probes for each DNA mutation identified at NRIP1 locus. Using these techniques, we genotyped the mutations in 200 unrelated women (59 endometriosis patients, 94 unselected controls and 47 super-control women). Overall, 400 different chromosomes have been scored for each DNA variant (Table 4).
###end p 38
###begin p 39
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 76 81 <span type="species:ncbi:9606">human</span>
Association studies of common DNA variants of the NRIP1 gene in relation to human endometriosis.
###end p 39
###begin p 40
###xml 10 18 <span type="species:ncbi:9606">patients</span>
*Compares patients versus merged controls. Best p value employing tests for genetic association according to Sasieni (1997). Ile441Val and His221Arg are not analyzed due to small or null sample size in endometriosis samples.
###end p 40
###begin p 41
###xml 185 193 185 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gly75Gly</italic>
###xml 195 215 195 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His221Arg, Ile441Val</italic>
###xml 217 227 217 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 231 240 231 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ser803Leu</italic>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 343 354 343 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val1079Phe </italic>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 386 393 <span type="species:ncbi:9606">patient</span>
By analyzing the allelic frequencies of DNA variants detected in Spanish population, we classified these variants as common polymorphisms if observed in >1% of chromosomes in controls (Gly75Gly, His221Arg, Ile441Val, Arg448Gly and Ser803Leu) or rare variants if observed with a frequency <1% of chromosomes in controls (Table 3). In contrast, Val1079Phe allele appears only in a single patient in heterozygous state and none of 141 controls. This data could suggest its involvement in the disease. Reinforcing this hypothesis, Val1079Phe is located close to high-conserved domain of the carboxylic end of RIP140 protein that interacts with retinoic acid nuclear receptor (Fig. 1).
###end p 41
###begin p 42
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 241 251 241 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 265 275 265 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His221Arg </italic>
###xml 278 289 278 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val1079Phe </italic>
###xml 392 412 392 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His221Arg/Arg448Gly </italic>
###xml 416 436 416 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val1079Phe/Arg448Gly</italic>
###xml 453 472 453 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly/Arg448Gly</italic>
###xml 533 552 533 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly/Arg448Gly</italic>
###xml 868 874 868 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 1023 1029 1023 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 136 141 <span type="species:ncbi:9606">women</span>
###xml 329 334 <span type="species:ncbi:9606">women</span>
###xml 675 680 <span type="species:ncbi:9606">women</span>
Direct inspection of genotypes in patients revealed three genotype patterns within the NRIP1 gene that appear to be over-represented in women affected by endometriosis (p = 0.006, Fisher exact test). The patterns consist of a combination of Arg448Gly together with His221Arg or Val1079Phe variants. We identified three unrelated women affected by endometriosis carrying double heterozygotes (His221Arg/Arg448Gly and Val1079Phe/Arg448Gly) or homozygote (Arg448Gly/Arg448Gly) genotypes for these alleles, respectively. The homozygote (Arg448Gly/Arg448Gly) genotype pattern appeared only in 1 of 94 unselected controls (p = 0.016 Fisher exact test) and none of 47 super-control women (p = 0.023, Fisher Exact test), whereas double heterozygotes genotypes did not appear in any control individual. These results suggest that specific combinations of amino acid changes at NRIP1 locus could be related to endometriosis etiology with a 99.4% of reliability, although given the scarce sample size the presence of polygenes within NRIP1 locus must be proven with a larger and independent re-analysis.
###end p 42
###begin p 43
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gy75Gly</italic>
###xml 153 163 153 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 167 176 167 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ser803Leu</italic>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 603 613 603 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 717 740 717 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allele positivity test </sub>
###xml 930 938 930 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gly75Gly</italic>
###xml 953 962 953 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly</italic>
###xml 980 989 980 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ser804Leu</italic>
###xml 855 860 <span type="species:ncbi:9606">women</span>
Finally, given the preliminary results, we conducted an small case-control study analyzing all common variants detected within the NRIP1 locus (Gy75Gly, Arg448Gly and Ser803Leu). Table 4 shows the results for those test that maximize the differences between case and control groups for each polymorphism. Genotypic distributions of polymorphisms analyzed are in accordance with the Hardy-Weinberg equilibrium law (p > 0.15), indicating no bias due to technical or stratification problems nor evolution-dependent genetic sweep/selection events (data not shown). Interestingly, our analysis revealed that Arg448Gly polymorphism appears to be weakly associated with endometriosis in our population (Odds ratio = 2.327, pallele positivity test = 0.027). In contrast, no significant association could be achieved when comparing unselected versus super-control women, supporting the accuracy of the selected control panel (p > 0.34 for Gly75Gly, p > 0.41 for Arg448Gly, and p > 0.1 for Ser804Leu).
###end p 43
###begin p 44
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
Overall, our results might support the role of NRIP1 gene in endometriosis, although given the small sample size, we propose an extensive re-analysis by increasing the sample size to confirm our results.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 246 266 246 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Estrogen Receptor 1 </italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESR1 </italic>
###xml 289 304 289 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cytochrome P450</italic>
###xml 306 315 306 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Family 19</italic>
###xml 317 328 317 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Subfamily A</italic>
###xml 330 344 330 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Polypeptide 1 </italic>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP19 </italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 517 539 517 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Progesterone Receptor </italic>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PGR </italic>
###xml 561 604 561 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Peroxisome Proliferative Activated Receptor</italic>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gamma </italic>
###xml 613 619 613 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG </italic>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 55 60 <span type="species:ncbi:9606">women</span>
###xml 272 276 <span type="species:ncbi:9606">OMIM</span>
###xml 351 355 <span type="species:ncbi:9606">OMIM</span>
###xml 544 548 <span type="species:ncbi:9606">OMIM</span>
###xml 619 623 <span type="species:ncbi:9606">OMIM</span>
Endometriosis is a complex disease affecting 10-15% of women at reproductive age. Very few genes are known to be altered in this pathology. Molecular genetic analyses provide some evidence of genetic association in case-control studies analyzing Estrogen Receptor 1 (ESR1 OMIM 133430) and Cytochrome P450, Family 19, Subfamily A, Polypeptide 1 (CYP19 OMIM 107910) genes. Interestingly, both loci are involved in oestrogen mechanism of production and action [12,13]. In addition, other nuclear receptor genes, such as Progesterone Receptor (PGR OMIM 607311) and Peroxisome Proliferative Activated Receptor, Gamma (PPARG OMIM 601487) gene have been associated with endometriosis in other case-control studies [14,15]. The involvement in endometriosis of loci related to detoxification has been also studied and replicated [16-18].
###end p 46
###begin p 47
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 328 333 <span type="species:ncbi:9606">human</span>
Given these preliminary findings and the importance of steroid receptors in uterine physiology [19] and endometriosis pathogenesis [1,20], the biochemical pathways involved in steroids production, degradation or mechanisms of action appear to be strong candidates for endometriosis etiology and many other phenotypes related to human fertility.
###end p 47
###begin p 48
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nrip1 </italic>
###xml 115 145 115 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CCR4-NOT transcription complex</italic>
###xml 147 157 147 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">subunit 7 </italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cnot7 </italic>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Following this working hypothesis, targeting disruption of nuclear receptors and their regulators such as nrip1 or CCR4-NOT transcription complex, subunit 7 (cnot7 GenBank ) in animal models have provided direct evidence of the importance of nuclear receptor homeostasis in male and female reproduction [3,21-24].
###end p 48
###begin p 49
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 674 683 674 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gly75Gly </italic>
###xml 705 715 705 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Here we present the first structural analysis of the human NRIP1 gene in relation to human disease. It is of interest to mention that the dbSNP includes 26 SNPs for NRIP1 gene currently. Eighteen of these variants are located within the 3'untranslated region (3'UTR), this genomic region has not been covered in this study, and the remaining ones are coding SNPs. According to GenBank, only three SNPs in the 3'UTR region and two coding SNPs have been validated in population based studies including more than 150 chromosomes. The rest of the SNPs are the result of the bioinformatic alignment of different cDNA and genomic clones. The allele frequencies here presented for Gly75Gly (dbSNP rs2229741) and Arg448Gly (dbSNP rs2229742) polymorphisms are very similar to those included in dbSNP (data not shown).
###end p 49
###begin p 50
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
###xml 762 770 <span type="species:ncbi:9606">patients</span>
Overall, our results are preliminary providingt suggestive, but not definitive, evidence of NRIP1 gene involvement in human endometriosis. We think that conclusive proofs of involvement will be achieved throughout re-analyses of this study in independent cohorts of patients and controls, rather than performing functional analyses of the missense mutations observed. The detection of functionality of DNA variants involved in complex traits such endometriosis, is near to be impossible using conventional technologies because the effect from single genetic variant/mutation is expected to be very small and it is only the joint effect of several susceptibility genes that leads to the disease [25]. In this sense, we are currently recruiting a higher number of patients and controls to perform a proper re-analysis of our results.
###end p 50
###begin p 51
###xml 10 20 10 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 453 462 453 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly</italic>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 349 355 <span type="species:ncbi:9606">humans</span>
###xml 357 361 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
Regarding Arg448Gly polymorphism, we propose that the variant could act as a low penetrance allele related to human endometriosis. The molecular mechanism of this mutation is not well understood, although its location and degree of conservation provide some interesting clues. In fact, Arg448 residue of RIP140 protein is completely conserved among humans, rats, mice, gallus and xenopus (Fig. 1b). Moreover, the non-conservative substitution detected (Arg448Gly) might affect the Carboxyl terminal binding protein (CTBP) interacting motif of RIP140 protein that is located close to this amino acid residue (Fig. 1b).
###end p 51
###begin p 52
###xml 69 79 69 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 252 263 252 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val1079Phe </italic>
###xml 276 286 276 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 329 340 329 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val1079Phe </italic>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 615 626 615 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Val1079Phe </italic>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1086 1088 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 46 51 <span type="species:ncbi:9606">women</span>
###xml 196 201 <span type="species:ncbi:9606">woman</span>
###xml 870 878 <span type="species:ncbi:9606">patients</span>
On the basis of genotype analysis in affected women, we propose that Arg448Gly mutation could act in concert with other genetic variants within NRIP1 or other loci. In this way, we found a single woman affected by endometriosis simultaneously carrying Val1079Phe mutation and Arg448Gly polymorphism both in a heterozygous state. Val1079Phe also arises in an inter-specific conserved residue. Moreover, this mutation is located close to (and may disrupt) the retinoid acid receptor interacting motif "LTKTNPILYYMLQK" of RIP140 protein (Fig. 1b). Supporting its involvement in the disease, we have not identified the Val1079Phe mutation in 282-control chromosomes. Intriguingly, retinoid acid receptors alpha, gamma 2 and its regulator cnot7 have been involved in male sterility [24,26,27]. Moreover, the presence of multiple specific functional rare variants in affected patients have been recently proposed and evaluated [28]. This hypothesis is an alternative to explain the genetic component of complex traits in front of the widely accepted common disease common variant hypothesis [29].
###end p 52
###begin p 53
###xml 90 100 90 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His221Arg </italic>
###xml 125 135 125 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 262 272 262 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His221Arg </italic>
###xml 316 326 316 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His221Arg </italic>
###xml 343 353 343 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His221Arg </italic>
###xml 380 390 380 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg448Gly </italic>
###xml 32 39 <span type="species:ncbi:9606">patient</span>
###xml 395 400 <span type="species:ncbi:9606">woman</span>
Finally, we identified a single patient carrying a unique genotype combination comprising His221Arg rare variant and, again, Arg448Gly polymorphism. The absence of inter-specific amino acidic conservation and the inexistence of known functional domains close to His221Arg variant do not support the functionality of His221Arg allele. However, His221Arg only appears combined with Arg448Gly in a woman affected by endometriosis. This combination never appears in 141 unrelated controls. Functional assays or large cohorts analyses will help to elucidate its involvement in this pathology.
###end p 53
###begin p 54
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 86 92 <span type="species:ncbi:9606">humans</span>
###xml 423 428 <span type="species:ncbi:9606">human</span>
Our results support that NRIP1 gene might contain alleles related to endometriosis in humans. NRIP1 gene encodes a highly pleiotropic nuclear receptor co-regulator (RIP140) [30]. This protein interacts and regulates multiple members of the nuclear receptor super-family. Some of them have been associated with endometriosis. The wide repertoire of RIP140 targets might explain the complex pathological findings observed in human endometriosis. In fact, a recent report revealed a complex mechanism, involved in endometriosis and other oestrogen-related traits, by which ER-mediated oestrogen signaling is modulated by a co-regulatory-like function of activated AhR/Arnt dioxin receptor complex, giving rise to adverse oestrogen-related actions of dioxin-type environmental contaminants [31]. Intriguingly, oestrogen and dioxin nuclear receptor pathways are modulated by RIP140 protein [32,33].
###end p 54
###begin p 55
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 234 240 234 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESR1 </italic>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ESR2</italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 457 463 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 122 127 <span type="species:ncbi:9606">human</span>
According to previous data, mouse models reports and the present results, NRIP1 gene appears to be an attractive gene for human endometriosis etiology and other related pathologies. In addition, we have found a genetic interaction of NRIP1 gene with Estrogen receptor alpha and beta (ESR1 and ESR2) genes in two estrogen-dependent diseases such as male infertility [34] and osteoporosis (manuscript in preparation). For these reasons, further evaluation of NRIP1 gene in many oestrogen-related phenotypes is warranted.
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRIP1 </italic>
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
Our results suggest that NRIP1 gene variants, separately or in combinations, might act as predisposing factors for human endometriosis. According to previous data, mouse models reports and the present results, NRIP1 appears to be an attractive candidate gene for human endometriosis etiology and other estrogen-related pathologies.
###end p 57
###begin title 58
Competing interests
###end title 58
###begin p 59
The author(s) declare that they have not competing interests.
###end p 59
###begin title 60
Authors' contributions
###end title 60
###begin p 61
###xml 78 86 <span type="species:ncbi:9606">patients</span>
VC, JAS, MC, MAL, FC and VL carried out the recruitment and classification of patients and controls and the biological samples management. RR and JJG carried out the molecular genetic studies and participate in the analysis and interpretation of data. LMR and AR carried out the design of the study, performed the statistical analyses and the interpretation of data.
###end p 61
###begin p 62
All authors have been involved in drafting the article or revising it critically for important intellectual content and have given final approval of the version to be published.
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
###xml 26 34 <span type="species:ncbi:9606">patients</span>
We are deeply grateful to patients and controls for participation in this study. Funded by the Ministerio de Ciencia y Tecnologia (MCYT, Spain, grant numbers FIT-010000-2003-36, FIT-010000-2003-89, FIT-010000-2003-70, PTQ2002-0206) and Organon Espanola S.A. (BCN, Spain).
###end p 64
###begin article-title 65
Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance
###end article-title 65
###begin article-title 66
###xml 64 69 <span type="species:ncbi:9606">women</span>
###xml 74 79 <span type="species:ncbi:9606">women</span>
Incidence of luteinized unruptured follicle syndrome in fertile women and women with endometriosis
###end article-title 66
###begin article-title 67
The nuclear receptor co-repressor Nrip1 (RIP140) is essential for female fertility
###end article-title 67
###begin article-title 68
Is the endometrium or oocyte/embryo affected in endometriosis?
###end article-title 68
###begin article-title 69
Endometriosis and recurrent pregnancy loss
###end article-title 69
###begin article-title 70
Nuclear receptor corepressor RIP140 regulates fat accumulation
###end article-title 70
###begin article-title 71
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
###end article-title 71
###begin article-title 72
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
###end article-title 72
###begin article-title 73
###xml 36 41 <span type="species:ncbi:9606">human</span>
Nomenclature for the description of human sequence variations
###end article-title 73
###begin article-title 74
CAPN10 alleles are associated with polycystic ovary syndrome
###end article-title 74
###begin article-title 75
From genotypes to genes: doubling the sample size
###end article-title 75
###begin article-title 76
Association of estrogen receptor gene polymorphisms with endometriosis
###end article-title 76
###begin article-title 77
###xml 98 103 <span type="species:ncbi:9606">women</span>
Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women
###end article-title 77
###begin article-title 78
PROGINS receptor gene polymorphism is associated with endometriosis
###end article-title 78
###begin article-title 79
Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis
###end article-title 79
###begin article-title 80
Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis
###end article-title 80
###begin article-title 81
Low-penetrance genes are associated with increased susceptibility to endometriosis
###end article-title 81
###begin article-title 82
CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis
###end article-title 82
###begin article-title 83
Steroid receptors in the uterus: implications in endometriosis
###end article-title 83
###begin article-title 84
Endometriosis: the pathophysiology as an estrogen-dependent disease
###end article-title 84
###begin article-title 85
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Abnormal spermatogenesis in RXR beta mutant mice
###end article-title 85
###begin article-title 86
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes
###end article-title 86
###begin article-title 87
Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility
###end article-title 87
###begin article-title 88
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta
###end article-title 88
###begin article-title 89
Genetic dissection of diseases: design and methods
###end article-title 89
###begin article-title 90
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Function of retinoic acid receptor gamma in the mouse
###end article-title 90
###begin article-title 91
Peroxisome proliferators disrupt retinoic acid receptor alpha signaling in the testis
###end article-title 91
###begin article-title 92
Multiple rare alleles contribute to low plasma levels of HDL cholesterol
###end article-title 92
###begin article-title 93
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
###end article-title 93
###begin article-title 94
Regulation of glucocorticoid receptor activity by 14-3-3-dependent intracellular relocalization of the corepressor RIP140
###end article-title 94
###begin article-title 95
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor
###end article-title 95
###begin article-title 96
Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs
###end article-title 96
###begin article-title 97
Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140
###end article-title 97
###begin article-title 98
Multilocus analyses of estrogen-related genes reveal the involvement of ESR1 gene in male infertility and the polygenic nature of the pathology
###end article-title 98

